Amcal stands by stroke check scheme

Amcal has defended its decision to partner with a service called Strokecheck that is offering cardiovascular risk assessments at around 300 of its pharmacies.

Pharmacists are paid a nominal fee to host a GP who assesses customers for stroke risk factors.

Those at high risk can be referred for an ultrasound of their carotid artery, aorta and peripheral arteries, performed by a sonographer at the pharmacy.

The scheme has come under fire from the Stroke Foundation because there is no clinical indication for carotid ultrasound if the patient has no symptoms.

Latest

Trending